Sign up to save your podcasts
Or
Share E16: Tocilizumab in Giant-Cell Arteritis - GIACTA
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E16: Tocilizumab in Giant-Cell Arteritis - GIACTA
Getting back to our usual format, this week we'll discuss the GIACTA trial, which compared various schedules of tocilizumab to various schedules of placebo and prednisone. It's an important trial that has changed the face of GCA and will be a refreshing RCT to discuss before we dive back into garbagey data next week.
View all episodes
By Michael Putman
4.9
111111 ratings
Getting back to our usual format, this week we'll discuss the GIACTA trial, which compared various schedules of tocilizumab to various schedules of placebo and prednisone. It's an important trial that has changed the face of GCA and will be a refreshing RCT to discuss before we dive back into garbagey data next week.
More shows like The Evidence Based Rheumatology Podcast
View all
JAMA Clinical Reviews
494 Listeners
Rheumnow Podcast
117 Listeners
The Curbsiders Internal Medicine Podcast
3,321 Listeners
Core IM | Internal Medicine Podcast
1,082 Listeners
Healio Rheuminations
119 Listeners
The Clinical Problem Solvers
515 Listeners
ACR on Air
67 Listeners
Around the Rheum
5 Listeners
Rheumatology For The Royal College
170 Listeners
RheumMadness Podcast
11 Listeners
The Lancet Rheumatology in conversation with
0 Listeners
Talking Rheumatology Research
1 Listeners
Talking Rheumatology
0 Listeners
Talking Rheumatology Spotlight
5 Listeners
ACR Journals On Air
18 Listeners